Image-guided interventional surgery firm Stereotaxis said it has extended an exclusive worldwide distribution agreement with the supplier of its magnetic ablation catheters through 2015.
As part of the extension, Stereotaxis' strategic partner has agreed to pursue an expanded indication -- the treatment of atrial fibrillation -- for the magnetic-irrigated catheter in the U.S., according to the St. Louis-based company. In addition, both firms have agreed to expand the product offering covered by the deal to include a next-generation irrigated magnetic catheter, which will include technological advances from both companies, Stereotaxis said.
The deal also covers further submissions for regulatory approval in new markets, such as Asia, for mutually agreed magnetic catheters, the company said. The exclusive distribution agreement for these products will expire at various later dates.
Related Reading
Stereotaxis Q3 affected by delays, October 14, 2010
Stereotaxis reports Q4 revenue growth, February 25, 2010
FDA clears Stereotaxis catheter, January 12, 2010
Stereotaxis reports revenue growth in Q3, November 6, 2009
Stereotaxis secures further credit, October 7, 2009
Copyright © 2011 AuntMinnie.com
